Our observation of the negative correlation between the tumor expression of corticosteroid receptor genes and plasma ACTH level suggests that lower receptors levels contribute to less effective negative regulation and possibly could affect lower adverse effect of GR antagonist on direct negative adrenal-pituitary feedback. The gene discussed is NR3C1; the disease is neoplasm.